PubMed دسترسی آزاد

Effects of Wilac D001 (Weissella confusa WIKIM51) Supplementation on Metabolic Parameters and Central Adiposity in Overweight Adults: A 12-Week Randomized, Double-Blind, Placebo-Controlled Trial.

استودیوی صوتی مقاله

پخش حرفه‌ای فارسی و انگلیسی

در حال بررسی نسخه‌های صوتی ذخیره‌شده…

صوت تولیدشده با هوش مصنوعی است. برای کاربرد علمی یا درمانی، متن و منبع اصلی را بررسی کنید.
خواندن هوشمند فارسی و انگلیسی در حال آماده‌سازی صداهای مرورگر…
تنظیم صدای طبیعی و سرعت

صداهایی که در نامشان «Natural»، «Neural» یا «Online» دیده می‌شود معمولاً طبیعی‌ترند. انتخاب صدا به صداهای نصب‌شده در ویندوز و مرورگر شما بستگی دارد.

چکیده اصلی

Recent research has emphasized the importance of gut microbiota in regulating energy and lipid metabolism as well as gut hormone secretion, indicating that probiotics could contribute to improving metabolic parameters associated with excess adiposity. This study evaluated the metabolic effects of Weissella confusa WIKIM51 (Wilac D001) and explored the potential involvement of glucagon-like peptide-1 (GLP-1)-related mechanisms. First, GLP-1 secretory activity following Wilac D001 treatment was evaluated in vitro using STC-1 enteroendocrine cells. Male C57BL/6 mice were fed a high-fat diet to induce obesity-associated metabolic dysregulation, and Wilac D001 was orally administered for 10 weeks. Glucose tolerance was subsequently examined using an oral glucose tolerance test (OGTT). Finally, in a 12-week randomized, double-blind, placebo-controlled clinical trial, overweight adults aged 19-64 years received either Wilac D001 (1.0 × 1010 colony-forming units/day) or a placebo. Blood lipid parameters, glycated hemoglobin, abdominal fat distribution, body composition, body weight, regional anthropometric measures, and lifestyle factors were evaluated. Wilac D001 significantly increased GLP-1 secretion in STC-1 cells versus the control (p < 0.01). High-fat diet-fed mice administered Wilac D001 exhibited lower fasting blood glucose levels and more rapid glucose recovery during the OGTT (p < 0.01). In the clinical trial, Wilac D001 supplementation led to reductions in several markers, including a significant reduction in triglyceride levels, alongside improvements in total abdominal fat area, visceral fat area, and subcutaneous fat area. No serious adverse events were reported. These findings support the potential of Wilac D001 as a functional probiotic for promoting microbiome-based metabolic health management.

متن کامل اصلی

نسخه دارای مجوز در منبع علمی در دسترس است.

لینک مستقیم از metadata منبع گرفته شده و در تب جدید باز می‌شود.

باز کردن متن کامل

کلیدواژه‌ها

Glucagon-like peptide-1Metabolic healthProbioticsWeissella confusa
در همین زیرشاخه

مقاله‌های مرتبط

PubMed2026

Glycaemic Variability and C-Peptide in Bangladeshi Children, Adolescents, and Young Adults With Diabetes: A Prospective Study.

OBJECTIVES: To characterise the magnitude of glycaemic variability and to examine the factors associated with it, with particular attention to residual beta-cell function measured by fasting C-peptide, in children, adolescents, and young adults with diabetes in Bangladesh. DESIGN AND SETTING: Prospective observational study at the BADAS Paediatric Diabetes Care and Research Centre, BIRDEM, Dhaka, using 14 days of blinded professional c…

PubMed2026

Comparative analysis of postprandial changes in the lipidome of capillary plasma and dry blood spots of young women.

PURPOSE: The postprandial period provides a dynamic window to assess metabolic function, as nutrient intake elicits measurable shifts in metabolism, that can be used to assess health status. Traditional venipuncture, though standard for blood sampling, poses practical limitations for postprandial studies that require repeated collections. This study evaluated the feasibility of using dry blood spots (DBS) as a minimally invasive altern…

PubMed2026

A Comprehensive Dual Platform, End-to-end Workflow for Metabolic Profiling of Dried Blood Microsamples.

Blood microsampling (BµS) has emerged as a robust, minimally invasive alternative to traditional venipuncture, enabling the collection of low-volume specimens outside conventional clinical settings. By supporting decentralized sampling and improving patient adherence, these devices can be integrated with advanced omics technologies to facilitate large-scale and longitudinal study designs. However, successful implementation requires opt…

PubMed2026

Effects of ultra-processed food reduction intervention on postprandial glucose and glycaemic variability in Korean young adults: study protocol for the ULTRA-CGM randomised controlled trial.

INTRODUCTION: High intake of ultra-processed foods (UPFs) is associated with an increased risk of type 2 diabetes. However, evidence from randomised controlled trials evaluating the effect of UPF reduction on postprandial glucose responses and glycaemic variability in young adults is limited. The Ultra-Processed Food Reduction Intervention and Continuous Glucose Monitoring (ULTRA-CGM) trial aims to evaluate the effects of a UPF-reducin…